David Hipkiss, CEO of Prosonix, recently spoke to in-Pharma technologist.com about the company's recent launch of its new UMAX^® particle engineering technology and how it is set to revolutionise the field of respiratory medicines.  Please see http://www.in-pharmatechnologist.com/Processing-QC/Prosonix-launches-UMAX-particle-tech-for-respiratory-drugs   For further details of the potential of UMAX^® particles in delivering better medicines for respiratory illness and disease please see the technology article on UMAX^® and technology launch news item: Prosonix Announce The Launch Of UMAX technology